ImmunoGen is now part of AbbVie | AbbVie
ImmunoGen is now part of AbbVie Together we will be working to make a remarkable impact for cancer patients and their communities of care, raising standards of care and advancing a …
AbbVie to Acquire ImmunoGen, including its Flagship Cancer …
2023年11月30日 · The acquisition accelerates AbbVie's commercial and clinical presence in the solid tumor space. Additionally, ImmunoGen's follow-on pipeline of promising next-generation …
AbbVie Completes Acquisition of ImmunoGen - Feb 12, 2024
2024年2月12日 · ImmunoGen's follow-on pipeline of ADCs further builds on AbbVie's existing solid tumor pipeline of novel targeted therapies and next-generation immuno-oncology assets, …
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities …
2025年1月6日 · Pipeline Priorities and Organizational Changes. Clinical Pipeline: ... (CAMP59) is a next generation topoisomerase-1 inhibitor licensed from AbbVie (formerly Immunogen), …
AbbVie Completes Acquisition of ImmunoGen - Yahoo Finance
2024年2月12日 · ImmunoGen's follow-on pipeline of ADCs further builds on AbbVie's existing solid tumor pipeline of novel targeted therapies and next-generation immuno-oncology assets, …
AbbVie concludes acquisition of ImmunoGen for $10.1bn
2024年2月13日 · AbbVie has completed the acquisition of ImmunoGen for $10.1bn, a move that significantly bolsters its oncology pipeline with promising treatments for solid tumours and …
2023年11月30日 · adding technologies, scientific expertise and a promising ADC pipeline targeting heme malignancies and solid tumors Maximizes ImmunoGen’s first-in-class folate …
AbbVie Completes ImmunoGen Acquisition, Expanding Cancer …
2024年2月14日 · AbbVie has completed its acquisition of ImmunoGen. The acquisition includes ImmunoGen’s flagship antibody-drug conjugate (ADC) ELAHERE® (mirvetuximab …
AbbVie Buys ImmunoGen in $10B Deal, Gains Access to ADC for ... - BioSpace
2023年11月30日 · Facing the loss of Humira revenues from biosimilar competition, AbbVie is looking to grow its pipeline by acquiring ImmunoGen and its antibody-drug conjugate Elahere, …
AbbVie Completes Acquisition of ImmunoGen - PR Newswire
2024年2月12日 · ImmunoGen's follow-on pipeline of ADCs further builds on AbbVie's existing solid tumor pipeline of novel targeted therapies and next-generation immuno-oncology assets, …